Mobile health solutions for atrial fibrillation detection and management: a systematic review.


Journal

Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123

Informations de publication

Date de publication:
May 2022
Historique:
received: 12 07 2021
accepted: 07 09 2021
pubmed: 23 9 2021
medline: 4 5 2022
entrez: 22 9 2021
Statut: ppublish

Résumé

We aimed to systematically review the available literature on mobile Health (mHealth) solutions, including handheld and wearable devices, implantable loop recorders (ILRs), as well as mobile platforms and support systems in atrial fibrillation (AF) detection and management. This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The electronic databases PubMed (NCBI), Embase (Ovid), and Cochrane were searched for articles published until 10 February 2021, inclusive. Given that the included studies varied widely in their design, interventions, comparators, and outcomes, no synthesis was undertaken, and we undertook a narrative review. We found 208 studies, which were deemed potentially relevant. Of these studies included, 82, 46, and 49 studies aimed at validating handheld devices, wearables, and ILRs for AF detection and/or management, respectively, while 34 studies assessed mobile platforms/support systems. The diagnostic accuracy of mHealth solutions differs with respect to the type (handheld devices vs wearables vs ILRs) and technology used (electrocardiography vs photoplethysmography), as well as application setting (intermittent vs continuous, spot vs longitudinal assessment), and study population. While the use of mHealth solutions in the detection and management of AF is becoming increasingly popular, its clinical implications merit further investigation and several barriers to widespread mHealth adaption in healthcare systems need to be overcome. Mobile health solutions for atrial fibrillation detection and management: a systematic review.

Identifiants

pubmed: 34549333
doi: 10.1007/s00392-021-01941-9
pii: 10.1007/s00392-021-01941-9
pmc: PMC8454991
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-491

Informations de copyright

© 2021. The Author(s).

Références

Europace. 2018 Jan 1;20(1):12-18
pubmed: 27733465
Telemed J E Health. 2021 Mar;27(3):296-302
pubmed: 32423358
JAMA Netw Open. 2020 Apr 1;3(4):e202064
pubmed: 32242908
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
JMIR Mhealth Uhealth. 2019 Mar 05;7(3):e11437
pubmed: 30835243
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
J Am Heart Assoc. 2016 Jul 21;5(7):
pubmed: 27444506
Glob Heart. 2014 Mar;9(1):113-9
pubmed: 25432121
N Engl J Med. 2019 Apr 18;380(16):1499-1508
pubmed: 30883054
Health Econ Rev. 2020 Jun 9;10(1):16
pubmed: 32519034
Am J Cardiol. 2018 May 15;121(10):1187-1191
pubmed: 29525063
Europace. 2019 Aug 1;21(8):1167-1175
pubmed: 31056678
JMIR Mhealth Uhealth. 2019 Mar 27;7(3):e12284
pubmed: 30916656
J Cardiovasc Electrophysiol. 2016 Jan;27(1):51-7
pubmed: 26391728
J Am Heart Assoc. 2018 Apr 5;7(8):
pubmed: 29622592
Europace. 2019 Jan 01;21(1):41-47
pubmed: 30085018
Eur Heart J Qual Care Clin Outcomes. 2021 Oct 28;7(6):574-582
pubmed: 32735316
Europace. 2017 May 01;19(5):753-757
pubmed: 27371660

Auteurs

Astrid N L Hermans (ANL)

Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.

Monika Gawalko (M)

Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.
Institute of Pharmacology, West German Heart and Vascular Centre, University Duisburg-Essen, Duisburg, Germany.
1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Lisa Dohmen (L)

Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.

Rachel M J van der Velden (RMJ)

Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.

Konstanze Betz (K)

Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.

David Duncker (D)

Department of Cardiology and Angiology, Hannover Heart Rhythm Center and Hannover Medical School, Hannover, Germany.

Dominique V M Verhaert (DVM)

Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.
Department of Cardiology, Radboud Institute for Health Sciences and Radboud University Medical Center, Nijmegen, The Netherlands.

Hein Heidbuchel (H)

Cardiology Department, Antwerp University Hospital and Antwerp University, Antwerp, Belgium.
Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.

Emma Svennberg (E)

Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

Lis Neubeck (L)

School of Health and Social Care, Edinburgh Napier University, Edinburgh, UK.

Jens Eckstein (J)

Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.

Deirdre A Lane (DA)

Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital and University of Liverpool, Liverpool, UK.

Gregory Y H Lip (GYH)

Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital and University of Liverpool, Liverpool, UK.

Harry J G M Crijns (HJGM)

Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.

Prashanthan Sanders (P)

Centre for Heart Rhythm Disorders, Royal Adelaide Hospital and University of Adelaide, Adelaide, Australia.

Jeroen M Hendriks (JM)

Centre for Heart Rhythm Disorders, Royal Adelaide Hospital and University of Adelaide, Adelaide, Australia.
Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, Australia.

Nikki A H A Pluymaekers (NAHA)

Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.

Dominik Linz (D)

Department of Cardiology, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands. dominik.linz@mumc.nl.
Department of Cardiology, Radboud Institute for Health Sciences and Radboud University Medical Center, Nijmegen, The Netherlands. dominik.linz@mumc.nl.
Centre for Heart Rhythm Disorders, Royal Adelaide Hospital and University of Adelaide, Adelaide, Australia. dominik.linz@mumc.nl.
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. dominik.linz@mumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH